Nicolas Wentzensen (United States of America)
US National Cancer Institute at the National Institute of Health Division of Cancer Epidemiology & Genetics , Clinical Genetics Branch
Presenter of 2 Presentations
EVALUATING COMBINED SCREENING AND TRIAGE STRATEGIES IN 4,600 WOMEN FROM THE IMPROVING RISK INFORMED HPV SCREENING (IRIS) STUDY (ID 1350)
Session Time
12:20 - 14:20
Session Type
Public Health Oral Session
Lecture Time
12:44 - 12:56
[{"name":"EVALUATING COMBINED SCREENING AND TRIAGE STRATEGIES IN 4,600 WOMEN FROM THE IMPROVING RISK INFORMED HPV SCREENING (IRIS) STUDY \u003Csmall\u003E(ID 1350)\u003C\/small\u003E","mode":"playlist","public":true,"info":{"id":1350,"presentation":"EVALUATING COMBINED SCREENING AND TRIAGE STRATEGIES IN 4,600 WOMEN FROM THE IMPROVING RISK INFORMED HPV SCREENING (IRIS) STUDY \u003Csmall\u003E(ID 1350)\u003C\/small\u003E","session":"Oral Session 13: SCREENING V. Evaluation and Impact of cervical cancer screening\u00a0","presenter":"Nicolas Wentzensen (United States of America)","photo":""},"playlist":[{"name":"Nicolas Wentzensen - EVALUATING COMBINED SCREENING AND TRIAGE STRATEGIES IN 4,600 WOMEN FROM THE IMP","source":"https:\/\/s3.eu-central-1.amazonaws.com\/eu-cslide-prod-recordings\/ipvc20\/40\/Nicolas Wentzensen - EVALUATING COMBINED SCREENING AND TRIAGE STRATEGIES IN 4,600 WOMEN FROM THE IMPROVING RISK INFORMED HPV SCREENING (IRIS) STUDY.mp4","source_path":"s3:\/\/eu-cslide-prod-recordings\/ipvc20\/40\/Nicolas Wentzensen - EVALUATING COMBINED SCREENING AND TRIAGE STRATEGIES IN 4,600 WOMEN FROM THE IMPROVING RISK INFORMED HPV SCREENING (IRIS) STUDY.mp4","cover":"https:\/\/s3.eu-central-1.amazonaws.com\/eu-cslide-prod-recordings\/ipvc20\/40\/26C69DD6.jpg","data":[],"tracks":[],"chapters":"https:\/\/s3.eu-central-1.amazonaws.com\/eu-cslide-prod-recordings\/ipvc20\/40\/Nicolas Wentzensen - EVALUATING COMBINED SCREENING AND TRIAGE STRATEGIES IN 4,600 WOMEN FROM THE IMPROVING RISK INFORMED HPV SCREENING (IRIS) STUDY.vtt"}]}]
{"provider":"CTI","provider_live":0,"type":1,"code":"7E22UU0ph"}
[session]
[presentation]
[presenter]
DEEP-LEARNING-BASED EVALUATION OF DUAL STAIN CYTOLOGY IMPROVES ACCURACY AND EFFICIENCY OF CERVICAL CANCER SCREENING (ID 1347)
Session Time
07:45 - 08:35
Session Type
Public Health Oral Session
Lecture Time
07:57 - 08:09
[{"name":"DEEP-LEARNING-BASED EVALUATION OF DUAL STAIN CYTOLOGY IMPROVES ACCURACY AND EFFICIENCY OF CERVICAL CANCER SCREENING \u003Csmall\u003E(ID 1347)\u003C\/small\u003E","mode":"playlist","public":true,"info":{"id":1347,"presentation":"DEEP-LEARNING-BASED EVALUATION OF DUAL STAIN CYTOLOGY IMPROVES ACCURACY AND EFFICIENCY OF CERVICAL CANCER SCREENING \u003Csmall\u003E(ID 1347)\u003C\/small\u003E","session":"Oral Session 3: SCREENING I. Artificial intelligence approaches in cervical cancer screening","presenter":"Nicolas Wentzensen (United States of America)","photo":""},"playlist":[{"name":"Nicolas Wentzensen -1347 - IPVC - DEEP-LEARNING-BASED EVALUATION OF DUAL STAIN CYTOLOGY IMPROVES ACC","source":"https:\/\/s3.eu-central-1.amazonaws.com\/eu-cslide-prod-recordings\/ipvc20\/27\/Nicolas Wentzensen -1347 - IPVC - DEEP-LEARNING-BASED EVALUATION OF DUAL STAIN CYTOLOGY IMPROVES ACCURACY AND EFFICIENCY OF CERVICAL CANCER SCREENING.mp4","source_path":"s3:\/\/eu-cslide-prod-recordings\/ipvc20\/27\/Nicolas Wentzensen -1347 - IPVC - DEEP-LEARNING-BASED EVALUATION OF DUAL STAIN CYTOLOGY IMPROVES ACCURACY AND EFFICIENCY OF CERVICAL CANCER SCREENING.mp4","cover":"https:\/\/s3.eu-central-1.amazonaws.com\/eu-cslide-prod-recordings\/ipvc20\/27\/62DC1882.jpg","data":[],"tracks":[],"chapters":"https:\/\/s3.eu-central-1.amazonaws.com\/eu-cslide-prod-recordings\/ipvc20\/27\/Nicolas Wentzensen -1347 - IPVC - DEEP-LEARNING-BASED EVALUATION OF DUAL STAIN CYTOLOGY IMPROVES ACCURACY AND EFFICIENCY OF CERVICAL CANCER SCREENING.vtt"}]}]
{"provider":"CTI","provider_live":0,"type":1,"code":"9E22UU0pe"}
[session]
[presentation]
[presenter]
Moderator of 1 Session
Session Type
Clinical Science Oral Session
Session Time
12:20 - 13:45
[{"name":"SYSTEMATIC ANALYSIS OF EIGHT DNA METHYLATION MARKERS DEMONSTRATES A COMPARABLE HIGH DIAGNOSTIC PERFORMANCE FOR CIN3 AND CERVICAL CANCER \u003Csmall\u003E(ID 240)\u003C\/small\u003E","mode":"playlist","public":true,"info":{"id":240,"presentation":"SYSTEMATIC ANALYSIS OF EIGHT DNA METHYLATION MARKERS DEMONSTRATES A COMPARABLE HIGH DIAGNOSTIC PERFORMANCE FOR CIN3 AND CERVICAL CANCER \u003Csmall\u003E(ID 240)\u003C\/small\u003E","session":"Oral Session 9: Biomarkers Cervix and Other Sites","presenter":"St\u00e8fanie Dick (Netherlands)","photo":""},"playlist":[{"name":"Evaluation of six methylation markers derived from genome-wide screens for detection of cervical pre","source":"https:\/\/s3.eu-central-1.amazonaws.com\/eu-cslide-prod-recordings\/ipvc20\/80\/Stefanie Dick IPVC20 240 SYSTEMATIC ANALYSIS OF EIGHT DNA METHYLATION MARKERS DEMONSTRATES A COMPARABLE HIGH DIAGNOSTIC PERFORMANCE FOR CIN3 AND CERVICAL CANCER.mp4","source_path":"s3:\/\/eu-cslide-prod-recordings\/ipvc20\/80\/Stefanie Dick IPVC20 240 SYSTEMATIC ANALYSIS OF EIGHT DNA METHYLATION MARKERS DEMONSTRATES A COMPARABLE HIGH DIAGNOSTIC PERFORMANCE FOR CIN3 AND CERVICAL CANCER.mp4","cover":"https:\/\/s3.eu-central-1.amazonaws.com\/eu-cslide-prod-recordings\/ipvc20\/80\/894E2D05.jpg","data":[],"tracks":[],"chapters":"https:\/\/s3.eu-central-1.amazonaws.com\/eu-cslide-prod-recordings\/ipvc20\/80\/Stefanie Dick IPVC20 240 SYSTEMATIC ANALYSIS OF EIGHT DNA METHYLATION MARKERS DEMONSTRATES A COMPARABLE HIGH DIAGNOSTIC PERFORMANCE FOR CIN3 AND CERVICAL CANCER.vtt"}]},{"name":"A first-in-human proof-of-concept trial of intravaginal artesunate to treat cervical intraepithelial neoplasia 2\/3 (CIN2\/3) \u003Csmall\u003E(ID 1488)\u003C\/small\u003E","mode":"playlist","public":true,"info":{"id":1488,"presentation":"A first-in-human proof-of-concept trial of intravaginal artesunate to treat cervical intraepithelial neoplasia 2\/3 (CIN2\/3) \u003Csmall\u003E(ID 1488)\u003C\/small\u003E","session":"Oral Session 9: Biomarkers Cervix and Other Sites","presenter":"C L. Trimble (United States of America)","photo":""},"playlist":[{"name":"A first-in-human proof-of-concept trial of intravaginal artesunate to treat cervical intraepithelial","source":"https:\/\/s3.eu-central-1.amazonaws.com\/eu-cslide-prod-recordings\/ipvc20\/80\/Connie Trimble - IPVC20 - 1488 - A first-in-human proof-of-concept trial of intravaginal artesunate to treat cervical intraepithelial neoplasia.mp4","source_path":"s3:\/\/eu-cslide-prod-recordings\/ipvc20\/80\/Connie Trimble - IPVC20 - 1488 - A first-in-human proof-of-concept trial of intravaginal artesunate to treat cervical intraepithelial neoplasia.mp4","cover":"https:\/\/s3.eu-central-1.amazonaws.com\/eu-cslide-prod-recordings\/ipvc20\/80\/BD91BCE.jpg","data":[],"tracks":[],"chapters":"https:\/\/s3.eu-central-1.amazonaws.com\/eu-cslide-prod-recordings\/ipvc20\/80\/Connie Trimble - IPVC20 - 1488 - A first-in-human proof-of-concept trial of intravaginal artesunate to treat cervical intraepithelial neoplasia.vtt"}]},{"name":"MOLECULAR PAP SMEAR: EXTERNAL VALIDATION OF HPV GENOTYPE AND HOST EPIGENETIC MARKERS AS A PREDICTIVE CLASSIFIER OF CERVICAL CYTOLOGY \u003Csmall\u003E(ID 221)\u003C\/small\u003E","mode":"playlist","public":true,"info":{"id":221,"presentation":"MOLECULAR PAP SMEAR: EXTERNAL VALIDATION OF HPV GENOTYPE AND HOST EPIGENETIC MARKERS AS A PREDICTIVE CLASSIFIER OF CERVICAL CYTOLOGY \u003Csmall\u003E(ID 221)\u003C\/small\u003E","session":"Oral Session 9: Biomarkers Cervix and Other Sites","presenter":"Jane Shen-Gunther (United States of America)","photo":""},"playlist":[{"name":"MOLECULAR PAP SMEAR: EXTERNAL VALIDATION OF HPV GENOTYPE AND HOST EPIGENETIC MARKERS AS A PREDICTIVE","source":"https:\/\/s3.eu-central-1.amazonaws.com\/eu-cslide-prod-recordings\/ipvc20\/80\/221 Jane Shen Gunther.mp4","source_path":"s3:\/\/eu-cslide-prod-recordings\/ipvc20\/80\/221 Jane Shen Gunther.mp4","cover":"https:\/\/s3.eu-central-1.amazonaws.com\/eu-cslide-prod-recordings\/ipvc20\/80\/2A58D443.jpg","data":[],"tracks":[],"chapters":"https:\/\/s3.eu-central-1.amazonaws.com\/eu-cslide-prod-recordings\/ipvc20\/80\/221 Jane Shen Gunther.vtt"}]},{"name":"EVALUATION OF TWO HYBRID CAPTURE BASED HPV ASSAY WITH HPV16 AND HPV18 GENOTYPING \u003Csmall\u003E(ID 664)\u003C\/small\u003E","mode":"playlist","public":true,"info":{"id":664,"presentation":"EVALUATION OF TWO HYBRID CAPTURE BASED HPV ASSAY WITH HPV16 AND HPV18 GENOTYPING \u003Csmall\u003E(ID 664)\u003C\/small\u003E","session":"Oral Session 9: Biomarkers Cervix and Other Sites","presenter":"Hongsheng Lu (China)","photo":""},"playlist":[{"name":"EVALUATION OF TWO HYBRID CAPTURE BASED HPV ASSAY WITH HPV16 AND HPV18 GENOTYPING","source":"https:\/\/s3.eu-central-1.amazonaws.com\/eu-cslide-prod-recordings\/ipvc20\/80\/Presentation 664 EVALUATION OF TWO HYBRID CAPTURE BASED HPV ASSAY WITH HPV16 AND HPV18 GENOTYPING.mp4","source_path":"s3:\/\/eu-cslide-prod-recordings\/ipvc20\/80\/Presentation 664 EVALUATION OF TWO HYBRID CAPTURE BASED HPV ASSAY WITH HPV16 AND HPV18 GENOTYPING.mp4","cover":"https:\/\/s3.eu-central-1.amazonaws.com\/eu-cslide-prod-recordings\/ipvc20\/80\/8A09285B.jpg","data":[],"tracks":[],"chapters":"https:\/\/s3.eu-central-1.amazonaws.com\/eu-cslide-prod-recordings\/ipvc20\/80\/Presentation 664 EVALUATION OF TWO HYBRID CAPTURE BASED HPV ASSAY WITH HPV16 AND HPV18 GENOTYPING.vtt"}]},{"name":"PD-L1\/PD-1 EXPRESSION PATTERN IN NORMAL, HIGH-GRADE SQUAMOUS INTRAEPITHELIAL LESIONS AND SQUAMOUS CELL CANCER OF THE ANUS \u003Csmall\u003E(ID 1325)\u003C\/small\u003E","mode":"playlist","public":true,"info":{"id":1325,"presentation":"PD-L1\/PD-1 EXPRESSION PATTERN IN NORMAL, HIGH-GRADE SQUAMOUS INTRAEPITHELIAL LESIONS AND SQUAMOUS CELL CANCER OF THE ANUS \u003Csmall\u003E(ID 1325)\u003C\/small\u003E","session":"Oral Session 9: Biomarkers Cervix and Other Sites","presenter":"Sona Chowdhury (United States of America)","photo":""},"playlist":[{"name":"PD-L1\/PD-1 EXPRESSION PATTERN IN NORMAL, HIGH-GRADE SQUAMOUS INTRAEPITHELIAL LESIONS AND SQUAMOUS CE","source":"https:\/\/s3.eu-central-1.amazonaws.com\/eu-cslide-prod-recordings\/ipvc20\/80\/Sona Chowdhury p1325 IPVC20.mp4","source_path":"s3:\/\/eu-cslide-prod-recordings\/ipvc20\/80\/Sona Chowdhury p1325 IPVC20.mp4","cover":"https:\/\/s3.eu-central-1.amazonaws.com\/eu-cslide-prod-recordings\/ipvc20\/80\/72F63426.jpg","data":[],"tracks":[],"chapters":"https:\/\/s3.eu-central-1.amazonaws.com\/eu-cslide-prod-recordings\/ipvc20\/80\/Sona Chowdhury p1325 IPVC20.vtt"}]},{"name":"PRE-THERAPEUTIC HPV CIRCULATING TUMORAL DNA QUANTIFICATION BY DROPLET-BASED DIGITAL PCR: A PROMISING PREDICTIVE AND PROGNOSTIC BIOMARKER FOR HPV-ASSOCIATED OROPHARYNGEAL CANCERS \u003Csmall\u003E(ID 242)\u003C\/small\u003E","mode":"playlist","public":true,"info":{"id":242,"presentation":"PRE-THERAPEUTIC HPV CIRCULATING TUMORAL DNA QUANTIFICATION BY DROPLET-BASED DIGITAL PCR: A PROMISING PREDICTIVE AND PROGNOSTIC BIOMARKER FOR HPV-ASSOCIATED OROPHARYNGEAL CANCERS \u003Csmall\u003E(ID 242)\u003C\/small\u003E","session":"Oral Session 9: Biomarkers Cervix and Other Sites","presenter":"H\u00e9l\u00e8ne P\u00e9r\u00e9 (France)","photo":""},"playlist":[{"name":"PRE-THERAPEUTIC HPV CIRCULATING TUMORAL DNA QUANTIFICATION BY DROPLET-BASED DIGITAL PCR: A PROMISING","source":"https:\/\/s3.eu-central-1.amazonaws.com\/eu-cslide-prod-recordings\/ipvc20\/80\/P--r-----R_.mp4","source_path":"s3:\/\/eu-cslide-prod-recordings\/ipvc20\/80\/P--r-----R_.mp4","cover":"https:\/\/s3.eu-central-1.amazonaws.com\/eu-cslide-prod-recordings\/ipvc20\/80\/1A3BB6EB.jpg","data":[],"tracks":[],"chapters":"https:\/\/s3.eu-central-1.amazonaws.com\/eu-cslide-prod-recordings\/ipvc20\/80\/P--r-----R_.vtt"}]}]
{"type":2,"code":"8E32UU02o"}
[session]
[presentation]
[presenter]
